Abstract
Background and Aim: The
novel coronavirus (SARS-CoV-2) that causes novel coronavirus pneumonia
(COVID-19) is the third fatal coronavirus. The prognosis of disease
varies depending on patient’s specialties. The aim of this study was to
evaluate the correlation of CBC parameters and ferritin levels at the
time of diagnosis with the prognosis of patients hospitalized due to
COVID 19.
Materials and Methods: In this retrospective study, 1320
patients hospitalized at the Aksaray University Training and Research
Hospital between July 2020 and December 2020 were evaluated.
Results: All of the patients were hospitalized because of
symptoms associated with COVID 19. There were 688 males and 632 females
with a median age of 70 (19-98) at the time of hospitalization with
COVID 19 symptoms. The median follow-up time was 7 (range, 1-57) days in
hospital for all patients. Median age was significantly higher in
patients who do not respond to treatment and have mortality
(p<0.001). Most of the patients with mortality were males
(p=0.001). There was a statistically significant difference in the
parameters other than monocyte and basophil among the hemogram
parameters checked at the time of presentation. Neutrophil / lymphocyte
ratio was significantly higher in patients with mortality
(p<0.001).
Conclusion: In conclusion, this study indicates that by using
the most simple and routine hematological tests at the time of COVID-19
diagnosis, it may be possible to predict a patient’s prognosis. This
will help patients receive early clinical care, reducing patient
mortality and aiding in the control and prevention of the outbreak.
Keywords: COVID-19, novel coronavirus, complete blood counts,
ferritin, prognosis